Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof of Concept Study: Treatment of Restless Legs Syndrome With the Hypocretin Antagonist Suvorexant

NCT03755310 is registered in ClinicalTrials.gov with Diego García-Borreguero, MD, PhD as lead sponsor.

NCT NCT03755310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03755310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof of Concept Study: Treatment of Restless Legs Syndrome With the Hypocretin Antagonist Suvorexant
Lead sponsor
Diego García-Borreguero, MD, PhD
Phase
Phase 2
Overall status
Unknown status
Start date
February 28, 2019
Completion date
March 31, 2020
Enrollment
43 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

restless legs syndrome